SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-21-040314
Filing Date
2021-08-04
Accepted
2021-08-04 16:21:07
Documents
60
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0621_inmunebio.htm   iXBRL 10-Q 577295
2 CERTIFICATION f10q0621ex31-1_inmunebio.htm EX-31.1 10580
3 CERTIFICATION f10q0621ex31-2_inmunebio.htm EX-31.2 10531
4 CERTIFICATION f10q0621ex32-1_inmunebio.htm EX-32.1 4226
5 CERTIFICATION f10q0621ex32-2_inmunebio.htm EX-32.2 4236
  Complete submission text file 0001213900-21-040314.txt   3976344

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE inmb-20210630.xsd EX-101.SCH 53573
7 XBRL CALCULATION FILE inmb-20210630_cal.xml EX-101.CAL 31395
8 XBRL DEFINITION FILE inmb-20210630_def.xml EX-101.DEF 242540
9 XBRL LABEL FILE inmb-20210630_lab.xml EX-101.LAB 462632
10 XBRL PRESENTATION FILE inmb-20210630_pre.xml EX-101.PRE 245702
11 EXTRACTED XBRL INSTANCE DOCUMENT f10q0621_inmunebio_htm.xml XML 341584
Mailing Address 1200 PROSPECT STREET SUITE 525 LA JOLLA CA 92037
Business Address 1200 PROSPECT STREET SUITE 525 LA JOLLA CA 92037 8589643720
Inmune Bio, Inc. (Filer) CIK: 0001711754 (see all company filings)

IRS No.: 475205835 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38793 | Film No.: 211144316
SIC: 2836 Biological Products, (No Diagnostic Substances)